Member Info for JBTs

Excellent interview with Anthony Tennyson on Proactive Investors...well worth a watch.

Https://www.proactiveinvestors.co.uk/companies/news/1067718/solvonis-therapeutics-strengthens-board-with-addition-of-dr-renata-crome.html

Beat me to it at just after 8!!!

Not yet seen...I will be steaming in tomorrow!!!!!!!

Https://www.thisismoney.co.uk/money/markets/article-14354675/SMALL-CAP-IDEA-Neuro-psych-specialist-Solvonis-emerges-takeover-wave.htm

The CEO mentioned in his interview yesterday the Phase 3 trial for ‘Alcohol Use Disorder’ that is in progress in partnership with the UK Dept of Health is only costing the company £800k.

He did not mention that this would normally cost approximately £20m.

Unbelievable!

Solvonis Therapeutics appear to be in a red hot sector right now.

Only days ago, J & J announced the purchase of psychiatric drug developer Intra- Cellular for $14.6B.

And over the previous few months,

Denmark’s Lundbeck bets on Epilepsy drug with $2.6B.

Bristol Myers Squibb acquires Karuna Therapeutics for $14B.

AbbVie acquires Cerevel Therapeutics for $8.8B.

Very few Neuroscience Companies on the LSE.

Astra Zeneca are selectively active in the space.

Autifony Neuroscience just did a £700m deal with Jazz Pharma.

Solvonis Therapeutics ready for take off!

On 18th Dec I note an account called ‘Vicbol57’ started writing negative, defamatory and untrue comment about Graft. The next day this account was deleted along with the comments.

On 19th Dec a new account was created ‘Matador57’ and this account starts once again to spread fake news and untrue comments about Graft.

I am of the opinion that ‘Vicbol57’ and ‘Matador57’ are accounts run by the same person. The same person being the bitter and disgraced ex-director Victor Bolduev!

Despite this load of rubbish from the ex-director as below I am saying now this is my number one stock pick for 2025.....

On 18th Dec I note an account called ‘Vicbol57’ started writing negative, defamatory and untrue comment about Graft. The next day this account was deleted along with the comments.

On 19th Dec a new account was created ‘Matador57’ and this account starts once again to spread fake news and untrue comments about Graft.

I am of the opinion that ‘Vicbol57’ and ‘Matador57’ are accounts run by the same person. The same person being the bitter and disgraced ex-director Victor Bolduev!

On Proactive!

Excellent interview with the Chairman....well worth a watch.

Great interview with lots to like!

The trial for AWKN-001 re Alcohol Use Disorder is only costing the company £800k and the UK Dept of Health are paying the other 2/3rds £1.4m.

Clearly someone at Awakn ( probably Prof David Nutt)has a great relationship with the UK dept. as normally this sort of trial would cost 10 x this amount.

Unbelievable!

This is fantastic news for GPL....this company was valued at £50m three years ago and due to the lack of interest in this sector and the Canadian market as a whole has resulted in a marvellous opportunity to acquire Awakn on the cheap. In my opinion Awakn is worth 5 times that and signals a realistic share price for GPL of .5p. Merry Christmas all.

Marvellous interview on Proactive with CEO...well worth a watch!

With this news, which is just the start, and dealmakers at the helm, I have a price target short term of 0.5p with the potential medium term to 1p.

All over the Laura Kuenssberg programme yesterday and also Trevor Phillips on Sky who says the Gov’t want to tackle the problem head on!

Bodes well for Graft polymer.

Now listen to me guys. This stock is the cheapest share in the market. I will eat my peaky blinders hat if they aren't 1p within 12 months!!!!!

Sell while you can ....another AIM fraud!

Well it appears they have and apart from that one wobble both Potts and Llado have excellent records in financing these AIM stocks especially in the African Mining sector. Very positive in my opinion.

Have a look at these two links I have found researching the sector Graft Polymer operate. It really does demonstrate the huge potential in the US and now we know why Dennis Purcell has joined as the new Chairman as he is clearly in the know!

https://www.fiercebiotech.com/biotech/abbvie-joins-psychedelic-push-inks-2b-next-gen-neuro-deal-gilgamesh?utm_source=Palo+Santo+Announcements&utm_campaign=e4315155ee-EMAIL_CAMPAIGN_2022_02_15_03_59_COPY_01&utm_medium=email&utm_term=0_f9229f0617-e4315155ee-391576192

https://www.pharmaceutical-technology.com/news/seaport-raises-225m-to-advance-portfolio-of-neuropsychiatric-prodrugs/